Is the prophylactic salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers an important factor for survival?: Experience of Institut Curie-Paris.

被引：0
|
作者：
Laki, F. [1 ]
Kirova, Y. M. [1 ]
Salmon, R. [1 ]
Asselain, B. [1 ]
Stoppa-Lyonnet, D. [1 ]
机构：
[1] Inst Curie, Paris, France
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2006年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S180 / S180
页数：1
相关论文
共 50 条
  • [41] Risk-reducing salpingo-oophorectomy in patients with germline mutations in BRCA1 or BRCA2
    Kauff, Noah D.
    Barakat, Richard R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (20) : 2921 - 2927
  • [42] Timing and acceptance of bilateral prophylactic salpingo-oophorectomy among BRCA1 and BRCA2 mutation carriers enrolled in an integrated community-based health care system
    Kwan, Karen W.
    Morton, Stephanie W.
    Chung, Joanie
    CANCER RESEARCH, 2022, 82 (04)
  • [43] Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation Carriers
    Metcalfe, Kelly
    Lynch, Henry T.
    Foulkes, William D.
    Tung, Nadine
    Kim-Sing, Charmaine
    Olopade, Olufunmilayo I.
    Eisen, Andrea
    Rosen, Barry
    Snyder, Carrie
    Gershman, Shelley
    Sun, Ping
    Narod, Steven A.
    JAMA ONCOLOGY, 2015, 1 (03) : 306 - 313
  • [44] Comparison of prophylactic oophorectomy specimens from carriers and noncarriers of a BRCA1 or BRCA2 gene mutation
    Stratton, JF
    Buckley, CH
    Lowe, D
    Ponder, BAJ
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (07) : 626 - 628
  • [45] Multidisciplinary management of patients with BRCA1 and BRCA2 mutations in Institut Curie of Paris
    不详
    EJC SUPPLEMENTS, 2006, 4 (02): : 74 - 75
  • [46] Combining risk-reducing salpingo-oophorectomy with mastectomy and reconstructive surgery in BRCA1 and BRCA2 mutation carrier
    Chen, L.
    Crawford, B.
    McLennan, J.
    Hwang, E. S.
    Foster, R.
    Powell, C. B.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [47] Effects of bilateral salpingo-oophorectomy on menopausal symptoms and sexual functioning among women with a BRCA1 or BRCA2 mutation
    Hall, Elizabeth
    Finch, Amy
    Jacobson, Michelle
    Rosen, Barry
    Metcalfe, Kelly
    Sun, Ping
    Narod, Steven A.
    Kotsopoulos, Joanne
    GYNECOLOGIC ONCOLOGY, 2019, 152 (01) : 145 - 150
  • [48] Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation Carriers
    Rebbeck, Timothy R.
    Kauff, Noah D.
    Domchek, Susan M.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (02): : 80 - 87
  • [49] Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriers
    Friebel, Tara M.
    Domchek, Susan M.
    Neuhausen, Susan L.
    Wagner, Theresa
    Evans, D. Gareth
    Isaacs, Claudine
    Garber, Judy E.
    Daly, Mary B.
    Eeles, Rosalind
    Matloff, Ellen
    Tomlinson, Gail
    Lynch, Henry T.
    Tung, Nadine
    Blum, Joanne L.
    Weitzel, Jeffrey
    Rubinstein, Wendy S.
    Ganz, Patricia A.
    Couch, Fergus
    Rebbeck, Timothy R.
    CLINICAL BREAST CANCER, 2007, 7 (11) : 875 - 882
  • [50] Histopathological Result after prophylactic bilateral Salpingo-Oophorectomy in Women with BRCA1/2 Mutation - single center Experience
    Ehmann, S.
    Ramspott, J. P.
    du Bois, A.
    Harter, P.
    Heitz, F.
    Schneider, S.
    Baert, T.
    Pauly, N.
    Traut, A.
    Heikaus, S.
    Ataseven, B.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (10) : E187 - E188
12345